PTXPRESCIENT THERAPEUTICS LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 21 Aug 2026, 19:34 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 21 Aug 2026, 19:32 | Appendix 4E and 2026 Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 27 July 2026, 22:36 | June 2026 Quarterly Update and Appendix 4C | Quarterly Reports | MS | 14014, 19004, 19009 | |
| 11 July 2026, 00:53 | Notification of cessation of securities - PTX | Other | — | 06027 | |
| 11 June 2026, 20:03 | PTX Dr Rosalind Wilson appointed as Chief Medical Officer | Presentations | — | 12008, 14014 | |
| 15 May 2026, 19:01 | Response to ASX Price Query | ASX Query | MS | 17003 | |
| 30 Apr 2026, 19:37 | Investor Presentation | Presentations | — | 03026 | |
| 30 Apr 2026, 19:25 | March 2026 Quarterly Update and Appendix 4C | Quarterly Reports | MS | 19003, 19008 | |
| 25 Feb 2026, 20:03 | Updated Securities Trading Policy | Company Administration | — | 14013 | |
| 25 Feb 2026, 04:00 | Appendix 4D and Half Year Financial Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 30 Jan 2026, 20:16 | December 2025 Quarterly Update and Appendix 4C | Quarterly Reports | MS | 14014, 19002, 19007 | |
| 20 Dec 2025, 00:18 | Notification regarding unquoted securities - PTX | Other | — | 06021 | |
| 15 Dec 2025, 20:10 | PTX secures EU Authorisation to commence PTX-100 Trial | Company Update | MS | 11001 | |
| 21 Nov 2025, 21:03 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 21 Nov 2025, 21:02 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 21 Nov 2025, 21:01 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 21 Nov 2025, 21:00 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 21 Nov 2025, 20:57 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 19 Nov 2025, 20:02 | PTX secures EU Orphan Drug Designation for PTX-100 in CTCL | Company Update | MS | 11001, 14014 | |
| 18 Nov 2025, 21:25 | Notification regarding unquoted securities - PTX | Other | — | 06021 | |
| 29 Oct 2025, 01:34 | Amended Constitution | Securities Administration | — | 12012 | |
| 15 Oct 2025, 03:42 | Results of Annual General Meeting | Meetings & Governance | — | 08003 | |
| 14 Oct 2025, 21:43 | Chair Address and CEO AGM Presentation | Presentations | — | 03026, 15002 | |
| 10 Oct 2025, 20:07 | September Quarterly Updated and Appendix 4C | Quarterly Reports | MS | 19001, 19006 | |
| 12 Sept 2025, 20:54 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 2 Sept 2025, 03:04 | Notification regarding unquoted securities - PTX | Other | — | 06021 | |
| 29 Aug 2025, 21:37 | Completion of Share Placement & s708A Cleansing Notice | Securities Administration | — | 06018 | |
| 29 Aug 2025, 21:34 | Application for quotation of securities - PTX | Other | — | 06020 | |
| 21 Aug 2025, 02:30 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 21 Aug 2025, 02:29 | Appendix 4E and 2025 Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 12 Aug 2025, 19:34 | Share Placement Progress and Cleansing Notice | Capital Raising | — | 06003, 06018 | |
| 12 Aug 2025, 19:31 | Application for quotation of securities - PTX | Other | — | 06020 | |
| 12 Aug 2025, 03:27 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 12 Aug 2025, 03:26 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 12 Aug 2025, 03:24 | Change of Director's Interest Notice | Director Interests | — | 02009 |
1–35 of 35
1 / 1